Metabolic reprogramming of fibroblast-like synoviocytes with a supramolecular nano-drug for osteoarthritis therapy
Source abstract
Abstract
Abstract Metabolic reprogramming is fundamental to synovium remodeling with drug delivery for osteoarthritis (OA) therapy. Mitochonic acid 5-MASM7@MnTBAP nanoparticles (MM@MT NPs) with various physicochemical properties and biological activities may be developed as a supramolecular nano-drug delivering to articulus for regulating mitochondrial metabolism of synovium. This study aims to explore the feasibility, efficacy, and mechanism of MM@MT NPs, which possibly excavates a novel perspective for OA therapy. Herein, for feasibility, MM@MT NPs has been indicated to possess excellent photothermal, reactive oxygen species (ROS) response, and oxygen release performances. For efficacy, MM@MT NPs has been confirmed to promote extracellular matrix (ECM) regeneration. For mechanism, MM@MT NPs has been illustrated to restore the mitochondrial membrane potential and recover the mitochondrial dynamics, which is beneficial for maintaining mitochondrial homeostasis. Moreover, MM@MT NPs has been demonstrated to stimulate the tricarboxylic acid (TCA) cycle and oxidative phosphorylation (OXPHOS) in mitochondria as well as enhance antioxidant capacity and eliminate oxidative stress, which is reflected in regulating the adenosine triphosphate (ATP) and ROS metabolism. Therefore, MM@MT NPs can remodel the homeostasis of mitochondria via reprogramming metabolism in synovium, which achieves the symptomatic and etiological treatments of OA.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Osteoarthritis Treatment and Mechanisms · Protein Hydrolysis and Bioactive Peptides · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (42)
Show source-provided references
1. Hunter DJ, Bierma-Zeinstra S (2019) Osteoarthritis. Lancet 393:1745–1759. https://doi.org/10.1016/S0140-6736(19)30417-910.1016/S0140-6736(19)30417-9 ↗
2. Yao Q, Wu X, Tao C, Gong W, Chen M, Qu M, Zhong Y, He T, Chen S, Xiao G (2023) Osteoarthritis: pathogenic signaling pathways and therapeutic targets. Signal Transduct Target Ther 8:56. https://doi.org/10.1038/s41392-023-01330-w10.1038/s41392-023-01330-w ↗
3. Kluzek S, Newton JL, Arden NK (2015) Is osteoarthritis a metabolic disorder? Br Med Bull 115:111–121. https://doi.org/10.1093/bmb/ldv02810.1093/bmb/ldv028 ↗
4. Wan J, He Z, Zhao Y, Hao X, Cui J, Chen A, Zhou J, Zhang J (2023) Novel strategy of senescence elimination via toxicity-exempted kinome perturbations by nanoliposome-based thermosensitive hydrogel for osteoarthritis therapy. Adv Compos Hybrid Ma 6:104. https://doi.org/10.1007/s42114-023-00673-w10.1007/s42114-023-00673-w ↗
5. Mobasheri A, Rayman MP, Gualillo O, Sellam J, Van Der Kraan P, Fearon U (2017) The role of metabolism in the pathogenesis of osteoarthritis. Nat Rev Rheumatol 13:302–311. https://doi.org/10.1038/nrrheum.2017.5010.1038/nrrheum.2017.50 ↗
6. Fearon U, Canavan M, Biniecka M, Veale DJ (2016) Hypoxia, mitochondrial dysfunction and synovial invasiveness in rheumatoid arthritis. Nat Rev Rheumatol 12:385–397. https://doi.org/10.1038/nrrheum.2016.6910.1038/nrrheum.2016.69 ↗
7. Chan DC (2020) Mitochondrial dynamics and its involvement in disease. Annu Rev Pathol 15:235–259. https://doi.org/10.1146/annurev-pathmechdis-012419-03271110.1146/annurev-pathmechdis-012419-032711 ↗
8. Hu H, Zhang W, Zhou Y, Zhao K, Kuang J, Liu X, Li G, Xi Y (2024) Engineered mitochondrial ROS scavenger nanocomplex to enhance lung biodistribution and reduce inflammation for the treatment of ARDS. Adv Compos Hybrid Ma 7:194. https://doi.org/10.1007/s42114-024-00989-110.1007/s42114-024-00989-1 ↗
9. Li B, Jiang T, Liu H, Miao Z, Fang D, Zheng L, Zhao J (2018) Andrographolide protects chondrocytes from oxidative stress injury by activation of the Keap1-Nrf2-Are signaling pathway. J Cell Physiol 234:561–571. https://doi.org/10.1002/jcp.2676910.1002/jcp.26769 ↗
10. Hosseinzadeh A, Kamrava SK, Joghataei MT, Darabi R, Shakeri-Zadeh A, Shahriari M, Reiter RJ, Ghaznavi H, Mehrzadi S (2016) Apoptosis signaling pathways in osteoarthritis and possible protective role of melatonin. J Pineal Res 61:411–425. https://doi.org/10.1111/jpi.1236210.1111/jpi.12362 ↗
11. Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, Mcgowan J, Towheed T, Welch V, Wells G, Tugwell P, American College Of R (2012) American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken) 64:465–474. https://doi.org/10.1002/acr.2159610.1002/acr.21596 ↗
12. Peng Y, Wang Y, Bai R, Shi K, Zhou H, Chen C (2024) Nanomaterials: recent advances in knee osteoarthritis treatment. Adv Healthc Mater 13:e2400615. https://doi.org/10.1002/adhm.20240061510.1002/adhm.202400615 ↗
13. Lei Q, Tan J, Yi S, Wu N, Wang Y, Wu H (2018) Mitochonic acid 5 activates the MAPK-ERK-yap signaling pathways to protect mouse microglial BV-2 cells against TNFalpha-induced apoptosis via increased Bnip3-related mitophagy. Cell Mol Biol Lett 23:14. https://doi.org/10.1186/s11658-018-0081-510.1186/s11658-018-0081-5 ↗
14. Zacharioudakis E, Agianian B, Kumar Mv V, Biris N, Garner TP, Rabinovich-Nikitin I, Ouchida AT, Margulets V, Nordstrom LU, Riley JS, Dolgalev I, Chen Y, Wittig AJH, Pekson R, Mathew C, Wei P, Tsirigos A, Tait SWG, Kirshenbaum LA, Kitsis RN, Gavathiotis E (2022) Modulating mitofusins to control mitochondrial function and signaling. Nat Commun 13:3775. https://doi.org/10.1038/s41467-022-31324-110.1038/s41467-022-31324-1 ↗
15. Zhou Q, Einert M, Schmitt H, Wang Z, Pankratz F, Olivier CB, Bode C, Liao JK, Moser M (2016) MnTBAP increases BMPR-II expression in endothelial cells and attenuates vascular inflammation. Vascul Pharmacol 84:67–73. https://doi.org/10.1016/j.vph.2016.07.00110.1016/j.vph.2016.07.001 ↗
16. Xie D, Kuang Y, Yuan B, Zhang Y, Ye C, Guo Y, Qiu H, Ren J, Alshammari SO, Alshammari QA, El-Bahy ZM, Zhao K, Guo Z, Rao Q, Yang S (2025) Convenient and highly efficient adsorption of diosmetin from lemon peel by magnetic surface molecularly imprinted polymers. J Mater Scitechnol 211:159–170. https://doi.org/10.1016/j.jmst.2024.06.00110.1016/j.jmst.2024.06.001 ↗
17. Kabdrakhmanova S, Joshy KS, Sathian A, Aryp K, Akatan K, Shaimardan E, Beisebekov M, Gulden T, Kabdrakhmanova A, Maussumbayeva A, Joseph TM, Thomas S (2023) Anti-bacterial activity of Kalzhat clay functionalized with Ag and Cu nanoparticles. Engineered Sci 26:972. https://doi.org/10.30919/es97210.30919/es972 ↗
18. Zeng X, Wang S, Peng Z, Wang M, Zhao K, Xu BB, Yin X, Ibrahim MM, GaM M, El-Bahy ZM, Guo Z, Xiang W, Wang J (2024) Rapid screening and sensing of stearoyl-CoA desaturase 1 (SCD1) inhibitors from ginger and their efficacy in ameliorating non-alcoholic fatty liver disease. J Food Meas Charact 18:6843–6857. https://doi.org/10.1007/s11694-024-02697-210.1007/s11694-024-02697-2 ↗
19. Zhao K, Qi L, Li Q, Wang Y, Qian C, Shi Z (2024) Self-absorbing multilayer skin-like composite with Phyllostachys nigra polysaccharides promotes wound healing. Adv Compos Hybrid Ma 7:225. https://doi.org/10.1007/s42114-024-01018-x10.1007/s42114-024-01018-x ↗
20. Lei S, Zhang J, Blum NT, Li M, Zhang DY, Yin W, Zhao F, Lin J, Huang P (2022) In vivo three-dimensional multispectral photoacoustic imaging of dual enzyme-driven cyclic cascade reaction for tumor catalytic therapy. Nat Commun 13:1298. https://doi.org/10.1038/s41467-022-29082-110.1038/s41467-022-29082-1 ↗
21. Pritzker KP, Gay S, Jimenez SA, Ostergaard K, Pelletier JP, Revell PA, Salter D, Van Den Berg WB (2006) Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage 14:13–29. https://doi.org/10.1016/j.joca.2005.07.01410.1016/j.joca.2005.07.014 ↗
22. Kan S, Duan M, Liu Y, Wang C, Xie J (2021) Role of mitochondria in physiology of chondrocytes and diseases of osteoarthritis and rheumatoid arthritis. Cartilage 13:1102S-1121S. https://doi.org/10.1177/1947603521106385810.1177/19476035211063858 ↗
23. Matsuhashi T, Sato T, Kanno SI et al (2017) Mitochonic Acid 5 (MA-5) Facilitates ATP synthase oligomerization and cell survival in various mitochondrial diseases. EBioMedicine 20:27–38. https://doi.org/10.1016/j.ebiom.2017.05.01610.1016/j.ebiom.2017.05.016 ↗
24. Wei FL, Wang TF, Wang CL, Zhang ZP, Zhao JW, Heng W, Tang Z, Du MR, Yan XD, Li XX, Guo Z, Qian JX, Zhou CP (2024) Cytoplasmic escape of mitochondrial DNA mediated by Mfn2 downregulation promotes microglial activation via cGas-sting axis in spinal cord injury. Adv Sci (Weinh) 11:e2305442. https://doi.org/10.1002/advs.20230544210.1002/advs.202305442 ↗
25. Cao X, Luo D, Li T, Huang Z, Zou W, Wang L, Lian K, Lin D (2020) MnTBAP inhibits bone loss in ovariectomized rats by reducing mitochondrial oxidative stress in osteoblasts. J Bone Miner Metab 38:27-37. https://doi.org/10.1007/s00774-019-01038-410.1007/s00774-019-01038-4 ↗
26. Zhou M, Zhou C, Chen D, Wu H, Zhang Z, Yang H, Ruan W, Zhou Y, Tan Z (2022) Mn decorated UIO-66 catalyst for gaseous toluene removal: synergistic effect of enhanced hydroxyl from H2O2. Fuel 309:122229. https://doi.org/10.1016/j.fuel.2021.12222910.1016/j.fuel.2021.122229 ↗
27. Grissa R, Martinez H, Cotte S, Galipaud J, Pecquenard B, Le Cras F (2017) Thorough XPS analyses on overlithiated manganese spinel cycled around the 3V plateau. Appl Surf Sci 411:449–456. https://doi.org/10.1016/j.apsusc.2017.03.20510.1016/j.apsusc.2017.03.205 ↗
28. Yu P, Li Y, Sun H, Zhang H, Kang H, Wang P, Xin Q, Ding C, Xie J, Li J (2023) Mimicking antioxidases and hyaluronan synthase: a zwitterionic nanozyme for photothermal therapy of osteoarthritis. Adv Mater 35:e2303299. https://doi.org/10.1002/adma.20230329910.1002/adma.202303299 ↗
29. Kalamegam G, Abbas M, Gari M, Alsehli H, Kadam R, Alkaff M, Chaudhary A, Al-Qahtani M, Abuzenadah A, Kafienah W, Mobasheri A (2016) Pelleted bone marrow derived mesenchymal stem cells are better protected from the deleterious effects of arthroscopic heat shock. Front Physiol 7:180. https://doi.org/10.3389/fphys.2016.0018010.3389/fphys.2016.00180 ↗
30. Mayer MP (2013) Hsp70 chaperone dynamics and molecular mechanism. Trends Biochem Sci 38:507–514. https://doi.org/10.1016/j.tibs.2013.08.00110.1016/j.tibs.2013.08.001 ↗
31. Rauch JN, Gestwicki JE (2014) Binding of human nucleotide exchange factors to heat shock protein 70 (Hsp70) generates functionally distinct complexes in vitro. J Biol Chem 289:1402–1414. https://doi.org/10.1074/jbc.M113.52199710.1074/jbc.M113.521997 ↗
32. Radons J (2016) The human HSP70 family of chaperones: where do we stand? Cell Stress Chaperones 21:379–404. https://doi.org/10.1007/s12192-016-0676-610.1007/s12192-016-0676-6 ↗
33. Rhee DK, Marcelino J, Baker M, Gong Y, Smits P, Lefebvre V, Jay GD, Stewart M, Wang H, Warman ML, Carpten JD (2005) The secreted glycoprotein lubricin protects cartilage surfaces and inhibits synovial cell overgrowth. J Clin Invest 115:622–631. https://doi.org/10.1172/JCI2226310.1172/JCI22263 ↗
34. Itano N, Sawai T, Yoshida M, Lenas P, Yamada Y, Imagawa M, Shinomura T, Hamaguchi M, Yoshida Y, Ohnuki Y, Miyauchi S, Spicer AP, Mcdonald JA, Kimata K (1999) Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem 274:25085–25092. https://doi.org/10.1074/jbc.274.35.2508510.1074/jbc.274.35.25085 ↗
35. Blewis ME, Lao BJ, Schumacher BL, Bugbee WD, Sah RL, Firestein GS (2010) Interactive cytokine regulation of synoviocyte lubricant secretion. Tissue Eng Part A 16:1329–1337. https://doi.org/10.1089/ten.TEA.2009.021010.1089/ten.TEA.2009.0210 ↗
36. Stefani RM, Halder SS, Estell EG, Lee AJ, Silverstein AM, Sobczak E, Chahine NO, Ateshian GA, Shah RP, Hung CT (2019) A functional tissue-engineered synovium model to study osteoarthritis progression and treatment. Tissue Eng Part A 25:538–553. https://doi.org/10.1089/ten.TEA.2018.014210.1089/ten.TEA.2018.0142 ↗
37. Harapas CR, Idiiatullina E, Al-Azab M, Hrovat-Schaale K, Reygaerts T, Steiner A, Laohamonthonkul P, Davidson S, Yu CH, Booty L, Masters SL (2022) Organellar homeostasis and innate immune sensing. Nat Rev Immunol 22:535–549. https://doi.org/10.1038/s41577-022-00682-810.1038/s41577-022-00682-8 ↗
38. Sorrentino V, Menzies KJ, Auwerx J (2018) Repairing mitochondrial dysfunction in disease. Annu Rev Pharmacol Toxicol 58:353–389. https://doi.org/10.1146/annurev-pharmtox-010716-10490810.1146/annurev-pharmtox-010716-104908 ↗
39. Ruiz-Vela A, Gonzalez De Buitrago G, Martinez AC (2002) Nuclear Apaf-1 and cytochrome c redistribution following stress-induced apoptosis. FEBS Lett 517:133–138. https://doi.org/10.1016/s0014-5793(02)02607-810.1016/s0014-5793(02)02607-8 ↗
40. Martinez-Reyes I, Chandel NS (2020) Mitochondrial TCA cycle metabolites control physiology and disease. Nat Commun 11:102. https://doi.org/10.1038/s41467-019-13668-310.1038/s41467-019-13668-3 ↗
41. Tang JX, Thompson K, Taylor RW, Olahova M (2020) Mitochondrial OXPHOS biogenesis: co-regulation of protein synthesis, import, and assembly pathways. Int J Mol Sci 21:3820. https://doi.org/10.3390/ijms2111382010.3390/ijms21113820 ↗
42. Schoenmann N, Tannenbaum N, Hodgeman RM, Raju RP (2023) Regulating mitochondrial metabolism by targeting pyruvate dehydrogenase with dichloroacetate, a metabolic messenger. Biochim Biophys Acta Mol Basis Dis 1869:166769. https://doi.org/10.1016/j.bbadis.2023.16676910.1016/j.bbadis.2023.166769 ↗